Login
$SILC
$42.00 +$1.90 (4.74%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q4 FY2025
As of Dec 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q4 FY2020
As of Dec 31, 2020
Q4 FY2019
As of Dec 31, 2019
Q4 FY2018
As of Dec 31, 2018
Q4 FY2017
As of Dec 31, 2017
Q4 FY2016
As of Dec 31, 2016
Q4 FY2015
As of Dec 31, 2015
Q4 FY2014
As of Dec 31, 2014
Q4 FY2013
As of Dec 31, 2013
Q4 FY2012
As of Dec 31, 2012
Q4 FY2011
As of Dec 31, 2011
Assets
Current assets
Cash and cash equivalents
Short-term bank deposits
Marketable securities
Accounts receivable:
Trade, net
Other
Inventories
Total current assets
Marketable securities
Assets held for employees' severance benefits
Deferred tax assets
Property, plant and equipment, net
Intangible assets, net
Operating leases right-of-use, net
Goodwill
Total assets
Liabilities and shareholders' equity
Current liabilities
Trade accounts payable
Other accounts payable and accrued expenses
Operating lease liabilities
Total current liabilities
Long-term liabilities
Operating lease liabilities
Liability for employees' severance benefits
Deferred tax liabilities
Total liabilities
Shareholders' equity
Ordinary shares, ILS 0.01 par value; 10,000,000 shares authorized; 7,747,274 and 7,793,274 issued as at December 31, 2024 and 2025, respectively; 5,766,286 and 5,706,142 outstanding as at December 31, 2024 and 2025, respectively
Additional paid-in capital
Treasury shares (at cost) 1,980,988 and 2,087,132 ordinary shares as at December 31, 2024 and 2025, respectively
Retained earnings
Total shareholders' equity
Total liabilities and shareholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support